Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bai An Xi Ye (百安洗液) is an approved traditional Chinese herbal medicine formulation developed and manufactured by Sinopharm Group Zhijun. It is formulated as a topical liquid wash containing several herbal extracts, including *Phellodendron amurense* bark (黄柏), *Sophora flavescens* root (苦参), *Eucalyptus globulus* leaf (大叶桉叶), *Taraxacum mongolicum* (蒲公英), *Kochia scoparia* fruit (地肤子), *Paeonia lactiflora* root (赤芍), *Cnidium monnieri* fruit (蛇床子), and Borneol (冰片). Bai An Xi Ye is primarily indicated for the treatment of gynecological inflammatory conditions, including vulvovaginitis, bacterial vaginosis, trichomoniasis, and vulvar pruritus. It exerts broad-spectrum antimicrobial, anti-inflammatory, and antipruritic effects to alleviate symptoms such as vaginal itching, burning sensations, and abnormal discharge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bai An Xi Ye.